🇺🇸 FDA
Patent

US 8865175

Increasing anti-IL-1α antibodies in a subject

granted A61PA61P9/00A61P9/10

Quick answer

US patent 8865175 (Increasing anti-IL-1α antibodies in a subject) held by XBIOTECH INC. expires Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
XBIOTECH INC.
Grant date
Tue Oct 21 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 16 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P9/00, A61P9/10